Tumor Suppressor Genes: The Body's Natural Defense Against Cancer
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD | Last reviewed: October 7, 2026
Quick Answer
Tumor suppressor genes are genes that make proteins to restrain cell growth and prevent tumors. [1] They protect the body by repairing DNA errors, making sure damaged cells die and keeping cell multiplication in check. [1] Mutations in these genes, whether inherited or acquired, are a major driver of many cancers.
What the research says
BRCA1 and BRCA2 mutations sharply raise lifetime breast and ovarian cancer risk. In an Ontario cohort of females who had BRCA testing, cumulative breast cancer incidence to age 80 was 62.1% for BRCA1 and 66.1% for BRCA2 carriers, versus 12.0% in the general population. Ovarian cancer incidence was 56.0% and 29.3%, versus 1.5% (Dossa et al., JAMA Network Open, 2026) [2].
Germline TP53 mutations often lead to cancer at a young age. In a Spanish series of 36 TP53 variant carriers from 18 families, 23 (63.9%) developed at least one cancer, the median age at first cancer was 36 years, and breast cancer made up 65% of first cancers (Mirete et al., Familial Cancer, 2026) [3].
BRCA2 raises the risk of some non-breast cancers more than BRCA1. In a prospective study of 1260 BRCA1 and 1058 BRCA2 carriers, BRCA2 carriers had higher rates of pancreatic cancer (SIR 6.6) and prostate cancer (SIR 3.6), while BRCA1 carriers showed little evidence of increased risk for other non-breast, non-ovarian cancers (Yang et al., BMC Medicine, 2026) [4].
What do tumor suppressor genes do?
Tumor suppressor genes keep your cells healthy by regulating the cell cycle. [1] Each cell contains DNA that holds these genes, and they carry the instructions for proteins that suppress overgrowth. Acting as a braking system, they stop cells from multiplying so fast that they form masses, or tumors. [1]
These genes also do high-stakes maintenance work. They make sure old or damaged cells go through programmed cell death (apoptosis) instead of continuing to divide. [1] They repair DNA damage so genetic errors are not copied into new cells. [1] This oversight is what keeps tumors from forming and spreading. [1]
Which tumor suppressor genes are key, and what risks are linked to them?
Researchers have identified many tumor suppressor genes, each with its own role in preventing certain cancers. The best known is TP53, often called "the guardian of the genome" because it is one of the most frequently altered genes in human cancer. When TP53 is mutated, the body loses one of its most important defenses against tumors.
BRCA1 and BRCA2 are strongly linked to breast and ovarian cancer, and BRCA2 is also linked to prostate and pancreatic cancer. [1] [2] [4] For a closer look at one breast cancer subtype, see our guide on triple-negative breast cancer. The RB1 gene was the first tumor suppressor discovered, and its mutation is linked to retinoblastoma, a rare eye cancer, as well as cancers of the lung and bladder. [1] PTEN changes are tied to breast, thyroid and endometrial cancers [1]; our article on thyroid cancer explains the thyroid side. Knowing these genes helps providers assess your cancer risk and plan the right tests.
Gene | Common Associated Cancers |
TP53 | Li-Fraumeni syndrome and many common cancers [1] |
BRCA1/BRCA2 | Breast and ovarian; BRCA2 also prostate and pancreatic [1] |
RB1 | Retinoblastoma, lung, bladder [1] |
APC | Colon cancer (familial adenomatous polyposis) [1] |
PTEN | Breast, thyroid, endometrial [1] |
CDKN2A | Melanoma, pancreatic [1] |
What are tumor suppressor gene mutations?
Mutations in tumor suppressor genes fall into two main types: inherited and acquired. Inherited mutations are passed down from your biological parents and are present in every cell from birth. Acquired mutations are far more common. [1] They develop during life because of exposures such as radiation or tobacco smoke, and because of random errors during cell division as the body ages. [1]
A key idea in cancer genetics is the "two-hit hypothesis." Most people have two copies of each tumor suppressor gene, one from each parent. Cancer generally develops only when both copies stop working. [1] If you inherit one mutated copy, you are already one hit closer to cancer, so you are more susceptible if the second copy is damaged later in life. [1]
How are tumor suppressor genes different from oncogenes?
To understand how cancer develops, it helps to compare tumor suppressor genes with oncogenes. Tumor suppressor genes act as the brakes on cell growth, while oncogenes act as the gas pedal. [1] In a healthy body the two systems work together so cells grow and divide only when needed.
When the balance breaks, either because the brakes fail or because the gas pedal gets stuck on, cells multiply unchecked. This imbalance is the hallmark of cancer. Blood or saliva tests can find these genetic changes and flag risk early, but they show susceptibility, not a cancer diagnosis. [1]
Conclusion and Outlook
Tumor suppressor genes work constantly to repair DNA and restrain abnormal cell growth. Mutations in them can raise cancer risk, but understanding how they work gives us tools for early detection and risk management. A healthy lifestyle and an honest talk with your provider about family history are the best ways to support these natural defenses.
Next Steps
If you have a family history of cancer, ask your healthcare provider whether genetic testing for tumor suppressor gene mutations is right for you.
Frequently Asked Questions
What are tumor suppressor genes?
Tumor suppressor genes are genes that make proteins to regulate cell growth and prevent tumors from forming.
How do tumor suppressor genes prevent cancer?
Tumor suppressor genes repair DNA damage, tell damaged cells to die and slow down cell division.
What is the "guardian of the genome"?
The guardian of the genome is a nickname for the TP53 gene, one of the most frequently altered genes in human cancer.
What happens when a tumor suppressor gene mutates?
The gene stops making a working protein, which allows cells to multiply without proper control.
Are all mutations inherited?
No. Most are acquired during a lifetime through aging, environmental exposures or errors in cell division.
What is the difference between tumor suppressor genes and oncogenes?
Tumor suppressors act as the brakes that slow growth, while oncogenes act as the gas pedal that speeds it up.
What is the two-hit hypothesis?
The two-hit hypothesis is the idea that cancer usually needs both copies of a tumor suppressor gene to be inactivated.
Can I test for these mutations?
Yes. Blood or saliva tests can identify mutations in genes such as BRCA1, BRCA2 and TP53.
Does having a mutation mean I will get cancer?
No. It means your risk is higher than the general population, not that cancer is certain.
What are BRCA1 and BRCA2 genes?
BRCA1 and BRCA2 are tumor suppressor genes that, when mutated, greatly raise the risk of breast and ovarian cancer.
How does environmental exposure affect these genes?
Tobacco smoke and radiation can cause acquired mutations that disable these protective genes.
What is apoptosis?
Apoptosis is programmed cell death, a process that tumor suppressor genes trigger in damaged or old cells.
Why is the RB1 gene important?
The RB1 gene was the first tumor suppressor gene discovered and is linked to retinoblastoma and other cancers.
Can lifestyle changes protect these genes?
You cannot fix an inherited mutation, but avoiding carcinogens such as tobacco can prevent new acquired mutations.
When should I consider genetic testing?
Talk to a healthcare provider if you have a strong family history of early-onset cancer or of specific cancers.
Related Reading
Understanding Oncogenes: The Genetic Drivers of Cancer explains the genes that push cells to grow when they are mutated.
Understanding Somatic and Germline Mutations: Origins and Health Impact covers the difference between inherited and acquired gene changes.
Li-Fraumeni Syndrome: Understanding Genetic Cancer Risks and Management explains the inherited TP53 condition that raises lifetime cancer risk.
BRCA Testing: Who Should Get It, How It Works and What Results Mean describes who should consider testing for BRCA1 and BRCA2 gene changes.
Sources
Cleveland Clinic. Tumor Suppressor Genes. Cleveland Clinic. Last updated July 7, 2025. https://my.clevelandclinic.org/health/body/24833-tumor-suppressor-genes
Dossa F, Metcalfe K, Ante Z, Liu N, Lerner-Ellis J, Eisen A, Baxter NN. Breast and ovarian cancer among individuals undergoing BRCA1 and BRCA2 testing. JAMA Netw Open. 2026;9(7):e2626334. PMID 42530926. https://doi.org/10.1001/jamanetworkopen.2026.26334
Mirete BG, Arias AF, Payá PR, et al. Genotypic and phenotypic characteristics of germline TP53 variant carriers: experience from two cancer genetic counseling units. Fam Cancer. 2026;25(2):58. PMID 42171906. https://doi.org/10.1007/s10689-026-00571-2
Yang R, MacInnis RJ, Milne RL, et al. Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study. BMC Med. 2026;24(1):223. PMID 41776557. https://doi.org/10.1186/s12916-026-04753-8
Medical disclaimer
This information is for educational purposes only and does not constitute medical advice. Always seek the guidance of a qualified healthcare provider about your cancer risk or genetic testing.
Comments